These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8632497)

  • 1. Re: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Laderoute MP
    J Natl Cancer Inst; 1996 Feb; 88(3-4):210-1. PubMed ID: 8632497
    [No Abstract]   [Full Text] [Related]  

  • 2. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen therapy and carcinogenic risk.
    Powles TJ; Hickish T
    J Natl Cancer Inst; 1995 Sep; 87(18):1343-5. PubMed ID: 7658489
    [No Abstract]   [Full Text] [Related]  

  • 4. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Gynaecological effects of tamoxifen.
    Lewis JP
    J Clin Pathol; 2000 Jun; 53(6):484. PubMed ID: 10911811
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy and malignancy.
    Fitzgerald CT; Elstein M; Mansel RE
    Br J Obstet Gynaecol; 1993 May; 100(5):408-10. PubMed ID: 8518237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
    Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.
    Pukkala E; Kyyrönen P; Sankila R; Holli K
    Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and cancer: an update.
    La Vecchia C; Franceschi S
    Eur J Cancer Prev; 2003 Feb; 12(1):3-4. PubMed ID: 12548104
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and female malignancy: what has the Million Women Study added to our knowledge?
    Marsden J
    J Fam Plann Reprod Health Care; 2007 Oct; 33(4):237-43. PubMed ID: 17925102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral contraceptives and cancer].
    Thomas DB
    Adv Contracept; 1993 Mar; 9 Suppl 1():31-48. PubMed ID: 8512029
    [No Abstract]   [Full Text] [Related]  

  • 15. Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis.
    Adani G; Filippini T; Wise LA; Halldorsson TI; Blaha L; Vinceti M
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1095-1106. PubMed ID: 32169997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of oral contraceptives and risk of cancer, a cohort study].
    Kumle M; Alsaker E; Lund E
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen use and cancer incidence: a review.
    Lupulescu A
    Cancer Invest; 1995; 13(3):287-95. PubMed ID: 7743382
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis of tamoxifen-associated endometrial cancer.
    Lasset C; Mignotte H; Bonadona V; Chauvin F
    J Clin Oncol; 1998 Jul; 16(7):2573. PubMed ID: 9667283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Gal D; Weiselberg L; Runowicz CD
    J Natl Cancer Inst; 1994 Aug; 86(16):1252-3; author reply 1255. PubMed ID: 8040896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.